Champion Investments, Inc.

Champion Investments, Inc.

CHAM
Champion Investments, Inc.US flagOther OTC
0.00
USD
- -
- -
7,548.00Market Cap
Champion Investments, Inc.
CHAM
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
FRC
- -
- -
Revenue per Share
- -
- -
Basic EPS, GAAP
- -
- -
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
0.01
-0.13
Book Value per Share
0.01
- -
Tangible Book Value per Share
75
75
Basic Weighted Avg Shares
- -
- -
Sales/Revenue/Turnover
- -
- -
Operating Margin (%)
- -
- -
Depreciation Expense
- -
- -
Net Income, GAAP
- -
- -
Effective Tax Rate (%)
-11.19
133
Profit Margin (%)
- -
- -
Working Capital
- -
- -
LT Debt
- -
- -
Total Equity
- -
- -
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-32.86%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
3,951.02%
Sales/Revenue/Turnover
- -
- -
-440.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Business
Champion Investments, Inc. (CHAM:OTCPK) operates as a publicly traded investment firm pursuing regulation as a Business Development Company, focusing on equity and venture capital investments in early-stage, emerging, small- to middle-market companies, micro-investments, high-growth opportunities, acquisitions, buyouts, and recapitalizations in the United States; it targets the technology, life sciences, medical, and consumer sectors, with preferences for companies generating revenues up to $1 million in emerging stages, $2 million to $25 million with 10%-30% EBITDA in recapitalizations, and under $25 million in high-growth phases, aiming for returns over three-to-seven-year horizons. The firm, founded in 2009 and headquartered in Houston, Texas, partners with entrepreneurial executives to execute proprietary strategies in underserved high-impact categories. It maintains operations through a leadership team including Chairman and CEO Dr. Kerri G. Schomette, CFO and Chief Compliance Officer Desmonde C. A. Cowdery, and Vice President of Investor Relations Adam Parsons. Recent investments include equity stakes in Dakota Life Sciences, an anti-infective pharmaceutical company; Active Faith, Inc., a Christian sports apparel brand; and Thru Pharma, LLC, an innovative pharmaceutical organization, alongside appointments of Desmonde C. A. Cowdery as CFO and Chief Compliance Officer and Robert Hill as an independent director.